Skip to content

Simulations Plus SLP Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
NeoGenomics logo
NeoGenomicsNEO
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
Azenta logo
AzentaAZTA

Other financials

Income statement

See full
Revenue$24.3M+8.3%
Gross profit$16.1M+23.0%
Operating income$5.6M+108%
Net income$4.5M+47.5%
EPS (diluted)$0.22+46.7%

Balance sheet

See full
Cash & equivalents$25.7M+134%
Total debt$508.0K-36.2%
Total equity$133.8M-29.4%
Total assets$146.5M-27.3%

Cash flow

See full
Operating cash flow$6.4M+13.1%
CapEx$46.0K-30.3%
Free cash flow$6.4M+13.6%

Valuation

See full
Market cap$366.73M+5.2%
Enterprise value$341.51M+6.0%
P/S4.6×+0.2×

Profitability

See full
Gross margin62%+6.7pp
Operating margin-84.3%
Net margin-78%-87.2pp
FCF margin29.5%+14.9pp

Returns & leverage

See full
Return on equity-38.8%-42.8pp
Debt / equity0.0×
Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Simulations Plus's common stock, shares authorized (in shares)?
Simulations Plus (SLP) reported common stock, shares authorized (in shares) of $50M in Q4 2025.
How has Simulations Plus's common stock, shares authorized (in shares) changed year-over-year?
Simulations Plus's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $50M to $50M.
What is the long-term trend for Simulations Plus's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Simulations Plus's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.